Desmoplastic Small Round Cell Tumor Clinical Trials

31 clinical trials for Desmoplastic Small Round Cell Tumor across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor — RECRUITING · PHASE1
• Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors — RECRUITING · PHASE1
• Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS — RECRUITING · PHASE2
• B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) — RECRUITING · PHASE1
• Lurbinectedin in FET-Fused Tumors — RECRUITING · PHASE1
• Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas — RECRUITING · PHASE1
• Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group — RECRUITING · NA
• Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor — RECRUITING
• IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) — RECRUITING · PHASE2
• MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma — RECRUITING · PHASE2
• Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial. — RECRUITING · PHASE1
• Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor — RECRUITING · PHASE2
• Phase II study of lurbinectedin and irinotecan in adult and young adult patients with advanced desmoplastic small round cell tumor (DSRCT) — TERMINATED · PHASE2
• CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor — COMPLETED · PHASE1
• A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum — ACTIVE_NOT_RECRUITING · PHASE2
• EWSR1 Immunotherapy in Ewing Sarcoma and DSRCT — NOT_YET_RECRUITING · PHASE1
• Tazemetostat Expanded Access Program for Adults With Solid Tumors — TERMINATED
• B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults — ACTIVE_NOT_RECRUITING · PHASE1
• Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults — ACTIVE_NOT_RECRUITING · PHASE1
• Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor — ACTIVE_NOT_RECRUITING · PHASE1
• Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults — TERMINATED · PHASE2
• Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease — WITHDRAWN · PHASE2
• A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma — COMPLETED · PHASE1
• Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors — TERMINATED · PHASE1
• Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas — OTHER · PHASE1
• A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) — OTHER · PHASE1
• Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors — COMPLETED · PHASE1
• A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma — OTHER · PHASE2
• French National Registry of Rare Peritoneal Surface Malignancies — OTHER
• Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer — COMPLETED · PHASE1

Refine this search